搜尋結果
4 天前 · Novavax stock ( NVAX) skyrocketed Friday, up 120% on the news that French drug and vaccine giant Sanofi ( SNY) is investing $1.2 billion in a deal for Novavax's COVID-19 vaccine as well as a minority stake in the struggling biotech company. The deal gave Novavax a much-needed cash boost, helping it reverse more than a year of declining value.
4 天前 · Shares in Novavax almost doubled after Sanofi struck a licensing deal worth up to $1.2bn to commercialise the struggling Covid-19 vaccine maker’s coronavirus jab and use the technology to ...
6 小時前 · Sanofi on Monday announced it would invest over 1 billion euros ($1.1 billion) to create new medicines and vaccine production capacities at three of its French sites. S&P 500 edges down, investors ...
1 天前 · By GlobalData. Under the agreement, Sanofi gains exclusive commercialisation rights for losmapimod outside of the US. Fulcrum will receive an upfront payment of $80m and is eligible to receive up to $975m in specified regulatory and sales-based milestones, totalling the deal value to more than $1bn. The drug is currently being investigated in ...
18 小時前 · Healthcare company Sanofi ( NASDAQ: SNY) to invest more than €1 billion to create new bioproduction capacity at three of its French sites, it said on Monday. These investments at Vitry, Le Trait ...
1 天前 · Sanofi will invest more than €1 billion ($1.08 billion) in new bioproduction capacity at three manufacturing sites in France as part of a €3.5 billion programme in the country. The latest ...
3 天前 · Novavax Inc. shares surged after the company signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a combined Covid-19 and flu shot. Novavax will receive $500 million ...
